NSN 6505-01-196-9501
Part Details | USP ALPRAZOLAM TABLETS
6505-01-196-9501
Alternate Parts: NDC00228202950, NDC00228-2029-50, 1445321, 6505NCM163278, F000083319, NDC59762372003, NDC59762-3720-03, NDC00378400305, NDC00378-4003-05, NDC67253090150, NDC67253-0901-50, NDC00009005503, NDC00009-0055-03, XANAX 0.5MG 500S, NDC00781107705, NDC00781-1077-05, 6505-01-196-9501, 01-196-9501, 6505011969501, 011969501
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | DEC 15, 1984 | 01-196-9501 | 37352 ( ALPRAZOLAM TABLETS, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-196-9501
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00228-2029-50 | 6LMB8 | ACTAVIS PHARMA, INC. |
| 1445321 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM163278 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| F000083319 | 48KC0 | GREENSTONE LLC. |
| NDC59762-3720-03 | 48KC0 | GREENSTONE LLC. |
| NDC00378-4003-05 | 3KJG9 | MYLAN PHARMACEUTICALS INC. |
| NDC67253-0901-50 | 0VZ14 | PAR PHARMACEUTICAL, INC.DBA PAR PHARMACEUTICAL |
| NDC00009-0055-03 | 86491 | PFIZER INC.DBA PFIZER |
| XANAX 0.5MG 500S | 86491 | PFIZER INC.DBA PFIZER |
| NDC00781-1077-05 | 0THL4 | SANDOZ INC. |
Technical Data | NSN 6505-01-196-9501
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB0.500 MILLIGRAMS ALPRAZOLAM |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| SPECIAL FEATURES | ALPRAZOLAM TABLETS,USP; SCHEDULE IV CONTROLLED SUBSTANCE; EACH TABLET FOR ORAL ADMINISTRATION CONTAINS 0.5 MILLIGRAMS OF ALPRAZOLAM AS THE ACTIVE INGREDIENT; STRENGTH: 0.5 MILLIGRAMS; STORE AT 20 TO 25 C (68 TO 77 F); ?SEE USP CONTROLLED ROOM TEMPERATURE| |
| PROTECTIVE STORAGE FEATURE | EXPIRATION DATED AND SECURITY STORAGE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | XANAX (ALPRAZOLAM) 0.5 MG TABLET, 500S |
| CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |